eXoZymes (NASDAQ:EXOZ) Releases Earnings Results

eXoZymes (NASDAQ:EXOZ) released its quarterly earnings results on Thursday. The company reported ($0.28) EPS for the quarter, FiscalAI reports.

eXoZymes Stock Down 2.5%

eXoZymes stock traded down $0.25 during midday trading on Friday, reaching $9.77. The stock had a trading volume of 172 shares, compared to its average volume of 2,482. The firm’s fifty day simple moving average is $9.11 and its 200-day simple moving average is $11.09. eXoZymes has a 1-year low of $7.08 and a 1-year high of $18.40. The stock has a market capitalization of $82.84 million, a P/E ratio of -8.57 and a beta of 2.85. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.51 and a current ratio of 2.51.

eXoZymes Company Profile

eXoZymes, Inc develops, manufactures and supplies a range of enzymes and reagents designed for molecular biology research and diagnostic applications. The company’s enzyme engineering platform underpins a portfolio of products aimed at supporting nucleic acid purification, amplification and analysis workflows.

Key offerings from eXoZymes include magnetic bead–based nucleic acid extraction kits, DNA polymerases, reverse transcriptases, proteases and custom enzyme services. In addition, the company provides molecular diagnostic test kits designed for pathogen detection, leveraging scalable production processes and quality systems aligned with regulatory standards.

eXoZymes serves academic research institutions, biotechnology and pharmaceutical companies, and clinical diagnostic laboratories worldwide.